Fed. Circ. Affirms PTAB Ax Of 2 Cancer Drug Patents
The Federal Circuit on Thursday affirmed Patent Trial and Appeal Board decisions invalidating claims in two Genentech patents covering its blockbuster cancer drug Herceptin, rejecting the biotechnology company's argument that the...To view the full article, register now.
Already a subscriber? Click here to view full article